They’ll ask about your symptoms and see if your face is unusually red. A few different tests can help determine if you have polycythemia vera. Blood tests. Blood tests can check if your red ...

Polycythemia vera (PV) is a type of blood cancer where ... despite not experiencing other symptoms. PV is considered a type of blood cancer due to the abnormal production of red blood cells.

When you have polycythemia vera, your body makes too many red blood ... You also have options to manage your symptoms. A low dose of aspirin can protect you from clots. Your doctor will tell ...

My symptoms bothered me enough that I brought ... That’s the first time I heard the words polycythemia vera, or PV. I wasn’t diagnosed yet—I’d need to take a test and see a hematologist ...

Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with ...

and had severe COVID-19 symptoms. Experts do not have enough information to say for sure whether there is a link between polycythemia vera and increased COVID-19 mortality. People with PV that has ...

The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.

Early results from the phase 1 SANRECO trial suggest that divesiran is safe and well tolerated, and may reduce the need for phlebotomy in patients with polycythemia vera by increasing hepcidin levels ...

Emerging treatments focus on reducing phlebotomy frequency and improving symptoms, though disease-modifying options are still lacking. Although polycythemia vera management remains focused on ...

For patients with a rare type of blood cancer, treatment might finally be coming out of the Dark Ages. People with the ...

Rusfertide (Protagonist Therapeutics/Takeda Pharmaceuticals) — administered as a once-weekly subcutaneous injection — also ...

CHICAGO -- The use of the investigational weekly subcutaneous injection rusfertide significantly reduced the need for ...